Jump to content

Medway School of Pharmacy

Medical examination in a doctor's room

Independent/Supplementary Prescribing - PCert

2022

Join our successful prescribing programme and qualify as a non-medical prescriber. Apply now for a September 2022 start date!

2022

Overview

This is a well-established and successful independent/supplementary prescribing programme for pharmacists, nurses, midwives, physiotherapists, podiatrists, radiographers and dietitians. 

It is a part-time, blended learning programme which leads to you qualifying as an independent prescriber (community and primary care pharmacists, nurses, midwives, physiotherapists, podiatrists, paramedics and therapeutic radiographers) or as a supplementary prescriber (diagnostic radiographers and dietitians). You develop the knowledge and skills to practise as prescribers and to meet the standards set by your respective professional/regulatory body. Available as eight or 12 months duration. Also available at Level 6 for nurses/midwives.

Is this programme right for me?

If you are a pharmacist, nurse, midwife, physiotherapist, podiatrist, radiographer or dietitian looking to become a prescriber this is the programme you are looking for.

We also run a 40-credit module as part of the University of Greenwich MSc Advanced Clinical Practice. If you are part of this Greenwich programme and have selected the Prescribing module then you do also need to complete our Prescribing Application form. 

We are no longer recruiting for the Clinically Enhanced Prescribing Programme, pharmacists working in hospital, mental health and community trusts, and CCG pharmacists are eligible for this programme. 

Hospital Pharmacists in the HEE LaSE area are eligible for funding for the Prescribing programme when taken in conjunction with our Clinical Consultation Assessment and Diagnosis short course module.

Entry points and application deadlines

We have two different programme lengths to choose from. You can study over the REGULAR eight months or choose the EXTENDED programme over 12 months. Priority for the regular length programme will be given to those with a clearly defined scope of practice. The extended programme is for all those who may prefer, or who will benefit from, a longer period of study. It is especially suitable for those studying at Level 6 and community pharmacists.

All application forms are to be emailed to pgtpharmadmin@kent.ac.uk 

Please do not post any application forms.

Cohorts for academic year (2021/2022):

  • June 2022(12 month version) - deadline 18 March 2022

Cohorts for academic year (2022/2023):

  • September 2022 (08 month version) 40 Credit MSc students only - deadline 03 June 2022
  • October 2022 (08 month version) - deadline 08 July 2022
  • January 2023 (08 month version) - deadline 21 October 2022

You can find upcoming cohort dates under Course Structure

All dates and deliveries subject to change.

Hospital Pharmacists in HEE LaSE Area

Your applications deadlines are different as you are also applying for our Clinical Consultation Assessment and Diagnosis Module. Please check the application form.

Teaching

The Prescribing Programme is delivered by distance learning with a total of nine in person study days at the University, plus 12 days clinical practice, overseen by a Practice Supervisor (nurses and midwives only)/designated prescribing practitioner (DPP). 

About Medway School of Pharmacy

Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.

The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.

The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.

National ratings

In the Research Excellence Framework (REF) 2014, research by the School of Pharmacy was ranked 8th in the UK for research intensity.

An impressive 100% of our research-active staff submitted to the REF and 93% of our research was judged to be of international quality, with 81% of this judged world-leading or internationally excellent. The School’s environment was judged to be conducive to supporting the development of world-leading research.

Project Titles Supervisors
Circadian Rhythms and Aging Dr Gurprit Lall, Dr Aiste Steponenaite
Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens Dr Nigel Temperton, Dr Simon Scott , Prof Jonathan Heeney (University of Cambridge)
Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics Dr Simon Scott , Dr Nigel Temperton, Dr Matthew Reeves (UCL)
Formulation of layered silicate-polymer composite particles for the potential oral delivery of biologics Dr Vivek Trivedi, Dr Vadim Sumbayev
The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers Dr Andrew J Hall, Dr Nigel Temperton
Deciphering the landscape of nucleoporin and lamin function in nucleocytoplasmic communication, nuclear scaffolding and transcriptional control in disease prevention Dr Fani Papagiannouli, Dr Gurprit Lall
Design, Synthesis and Biological Evaluation of Tumour Targeting Analogues of Combretastatin A4 Dr M A Casely-Hayford, Dr N Lavignac, Dr V Sumbayev
Cross-modal sensory integration for motor decision making. Dr Stella Koutsikou, Dr Tobias von der Haar
Development of lipid-polymer hybrid nanoparticles via microfluidics, for the intracellular delivery of nucleic acid therapeutics Dr Nathalie Lavignac, Dr Vladimir Gubala
Cross-talks of immune checkpoint pathways determine the abilities of human malignant tumours to suppress cytotoxic attacks and escape immune surveillance Dr Vadim V Sumbayev
Understanding the genetic and molecular mechanisms of severe COVID-19 disease Dr Romina Vuono, Dr Athina Mylona
Traumatic Brain Injury and its link to Alzheimer's disease Dr Romina Vuono